Parkwood LLC grew its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 11.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,505 shares of the company's stock after buying an additional 4,037 shares during the quarter. Parkwood LLC's holdings in Procter & Gamble were worth $6,562,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Unique Wealth LLC raised its holdings in shares of Procter & Gamble by 2.9% in the 1st quarter. Unique Wealth LLC now owns 2,141 shares of the company's stock worth $365,000 after purchasing an additional 61 shares in the last quarter. Stableford Capital II LLC raised its holdings in shares of Procter & Gamble by 1.1% in the 1st quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock worth $993,000 after purchasing an additional 61 shares in the last quarter. Bernard Wealth Management Corp. raised its holdings in shares of Procter & Gamble by 20.2% in the 1st quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock worth $64,000 after purchasing an additional 63 shares in the last quarter. B & T Capital Management DBA Alpha Capital Management raised its holdings in shares of Procter & Gamble by 2.3% in the 1st quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company's stock worth $476,000 after purchasing an additional 63 shares in the last quarter. Finally, Kolinsky Wealth Management LLC raised its holdings in shares of Procter & Gamble by 1.1% in the 4th quarter. Kolinsky Wealth Management LLC now owns 5,738 shares of the company's stock worth $962,000 after purchasing an additional 64 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Stock Performance
Shares of PG opened at $160.08 on Friday. The company's 50 day moving average price is $156.41 and its 200 day moving average price is $162.28. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The company has a market capitalization of $374.65 billion, a PE ratio of 24.59, a PEG ratio of 4.20 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same period in the previous year, the firm posted $1.40 earnings per share. The firm's revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.6%. Procter & Gamble's payout ratio is 64.82%.
Analyst Ratings Changes
A number of research firms recently commented on PG. BNP Paribas reiterated an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Evercore ISI reissued an "in-line" rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Wells Fargo & Company dropped their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Finally, Barclays set a $164.00 target price on shares of Procter & Gamble and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and an average target price of $175.12.
Get Our Latest Report on Procter & Gamble
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the sale, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jennifer L. Davis sold 8,596 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the completion of the sale, the chief executive officer owned 64,991 shares of the company's stock, valued at $10,221,134.57. This trade represents a 11.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 120,181 shares of company stock valued at $18,918,012. Insiders own 0.18% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.